OneSource partners with Formycon for biosimilars manufacturing

14 Jul 2026via NSE FilingSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

OneSource partners with Formycon for biosimilars manufacturing. Onesource Specialty Pharma has entered a strategic manufacturing partnership with Germany’s Formycon AG to produce biosimilars. The collaboration aims to leverage Formycon’s technology and Onesource’s production capabilities. No financial terms of the deal were disclosed.

📊 STOCKS: ONESOURCE | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Biosimilars

#Biosimilars#Partnership#Manufacturing

Stocks mentioned

ONESOURCEONESOURCE

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →